0
0
May 7, 2025
For decades, the lipid profile-measuring cholesterol and triglycerides-has been the gold standard for assessing heart disease risk. However, emerging research and expert insights are now urging both physicians and patients to look beyond cholesterol numbers to get a more comprehensive picture of cardiac health.
The Limitations of Traditional Lipid Testing
While low-density lipoprotein (LDL), often dubbed “bad cholesterol,” has been the primary focus, many patients suffer heart attacks despite having normal LDL levels. This paradox has led cardiologists to explore other factors that contribute to atherosclerosis-the buildup of plaques that clog arteries and trigger heart attacks and strokes.
The Role of Inflammation: CRP and hs-CRP
Inflammation has emerged as a key player in heart disease. Dr. Suhas Hardas, a senior interventional cardiologist, explains that cholesterol alone does not tell the full story. Tests such as C-reactive protein (CRP) and its more specific form, high-sensitivity CRP (hs-CRP), detect inflammation in the blood vessels.
-
CRP is a general marker of inflammation and can rise due to infections or autoimmune diseases.
-
hs-CRP is more sensitive and indicates chronic, low-grade inflammation in the arteries, which can destabilize plaques and increase the risk of heart attacks.
A patient with normal LDL but elevated hs-CRP may still face serious cardiac risk, underscoring the importance of these tests in routine screening.
Genetic and Nutritional Markers: Lipoprotein(a) and Homocysteine
Beyond inflammation, genetic factors also influence heart risk. Lipoprotein(a), or Lp(a), is a genetically inherited form of bad cholesterol that can accelerate premature atherosclerosis. It often goes undetected unless specifically tested for.
Homocysteine, an amino acid linked to protein synthesis, is another important marker. Elevated homocysteine levels, often due to deficiencies in vitamins B6, B12, or folic acid, are associated with increased risk of heart disease, stroke, and even Alzheimer’s disease. Supplementing these vitamins can help mitigate vascular damage.
Advanced Testing: MPO and TMAO
Cutting-edge tests like Myeloperoxidase (MPO) and Trimethylamine N-oxide (TMAO) provide additional insights:
-
MPO measures oxidative stress and inflammation in arteries.
-
TMAO is linked to gut microbiome health and diet, with higher levels correlating with increased cardiac risk.
These tests are not yet routine but may be valuable in complex or high-risk cases.
Treatment and Prevention
Fortunately, treatments exist to manage these emerging risk factors:
-
Statins like rosuvastatin not only lower LDL cholesterol but also reduce hs-CRP levels, tackling inflammation.
-
Lifestyle modifications remain crucial for managing Lp(a) levels, though targeted therapies are still under research.
-
Vitamin B supplements can effectively lower homocysteine levels.
The Importance of Awareness for Physicians and Patients
General physicians and family doctors play a critical role in early detection. Relying solely on lipid profiles may miss underlying inflammation or genetic risks. Increased awareness and proactive testing can prevent major cardiac events.
Dr. Hardas advises patients not to be complacent if their cholesterol levels are normal. “Cholesterol is just one piece of the puzzle. Inflammation, genetics, and micronutrient deficiencies can silently raise your risk. If you have a family history of heart disease or other risk factors, ask your doctor about hs-CRP, Lp(a), and homocysteine testing. Prevention starts with awareness.”
Disclaimer
This article is for informational purposes only and does not substitute professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment tailored to your individual health needs.
Citations:
